BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17065424)

  • 1. Rapid mutation screening for HRPT2 and MEN1 mutations associated with familial and sporadic primary hyperparathyroidism.
    Howell VM; Cardinal JW; Richardson AL; Gimm O; Robinson BG; Marsh DJ
    J Mol Diagn; 2006 Nov; 8(5):559-66. PubMed ID: 17065424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
    Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
    J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
    Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic defects associated with familial and sporadic hyperparathyroidism.
    Hendy GN; Cole DE
    Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors.
    Uchino S; Noguchi S; Sato M; Yamashita H; Yamashita H; Watanabe S; Murakami T; Toda M; Ohshima A; Futata T; Mizukoshi T; Koike E; Takatsu K; Terao K; Wakiya S; Nagatomo M; Adachi M
    Cancer Res; 2000 Oct; 60(19):5553-7. PubMed ID: 11034102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management.
    Cetani F; Pardi E; Ambrogini E; Lemmi M; Borsari S; Cianferotti L; Vignali E; Viacava P; Berti P; Mariotti S; Pinchera A; Marcocci C
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):146-52. PubMed ID: 16430712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
    Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
    Shattuck TM; Välimäki S; Obara T; Gaz RD; Clark OH; Shoback D; Wierman ME; Tojo K; Robbins CM; Carpten JD; Farnebo LO; Larsson C; Arnold A
    N Engl J Med; 2003 Oct; 349(18):1722-9. PubMed ID: 14585940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas.
    Haven CJ; van Puijenbroek M; Tan MH; Teh BT; Fleuren GJ; van Wezel T; Morreau H
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):370-6. PubMed ID: 17555500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.
    Karges W; Jostarndt K; Maier S; Flemming A; Weitz M; Wissmann A; Feldmann B; Dralle H; Wagner P; Boehm BO
    J Endocrinol; 2000 Jul; 166(1):1-9. PubMed ID: 10856877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of primary hyperparathyroidism.
    Cetani F; Pardi E; Borsari S; Marcocci C
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation.
    Cetani F; Pardi E; Ambrogini E; Viacava P; Borsari S; Lemmi M; Cianferotti L; Miccoli P; Pinchera A; Arnold A; Marcocci C
    Endocr Relat Cancer; 2007 Jun; 14(2):493-9. PubMed ID: 17639062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperparathyroidism-jaw tumor syndrome. A hereditary form of primary hyperparathyroidism with parathyroid carcinoma].
    Raue F; Haag Ch; Frank-Raue K
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1459-62. PubMed ID: 17583828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
    Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
    Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
    Bricaire L; Odou MF; Cardot-Bauters C; Delemer B; North MO; Salenave S; Vezzosi D; Kuhn JM; Murat A; Caron P; Sadoul JL; Silve C; Chanson P; Barlier A; Clauser E; Porchet N; Groussin L;
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E403-8. PubMed ID: 23293331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of mutant menin stability with clinical expression of multiple endocrine neoplasia type 1 and its incomplete forms.
    Shimazu S; Nagamura Y; Yaguchi H; Ohkura N; Tsukada T
    Cancer Sci; 2011 Nov; 102(11):2097-102. PubMed ID: 21819486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the Danish families with multiple endocrine neoplasia type 1.
    Jäger AC; Friis-Hansen L; Hansen TV; Eskildsen PC; Sølling K; Knigge U; Hansen CP; Andersen PH; Brixen K; Feldt-Rasmussen U; Kroustrup JP; Mollerup CL; Rehfeld JF; Blichert-Toft M; Nielsen FC
    Mol Cell Endocrinol; 2006 Apr; 249(1-2):123-32. PubMed ID: 16563611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in patients with sporadic, nonfamilial primary hyperparathyroidism.
    Sato K; Yamazaki K; Zhu H; Kanbe M; Iihara M; Wada Y; Tanaka R; Okamoto T; Ito Y; Obara T
    Surgery; 2000 Mar; 127(3):337-41. PubMed ID: 10715991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.
    Scarpelli D; D'Aloiso L; Arturi F; Scillitani A; Presta I; Bisceglia M; Cristofaro C; Russo D; Filetti S
    J Endocrinol Invest; 2004 Dec; 27(11):1015-21. PubMed ID: 15754732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial isolated primary hyperparathyroidism due to HRPT2 mutation.
    Ghemigian A; Ghemigian M; Popescu I; Vija L; Petrova E; Dumitru N; Dumitru I
    Hormones (Athens); 2013; 12(3):454-60. PubMed ID: 24121387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.